Biocon has notched up yet another partnership deal on liraglutide, striking an agreement with Korean firm Handok for its generic version of the chronic weight management treatment.
Biocon Lines Up Another Liraglutide Deal, This Time In Korea
Follows Previous Partnerships Agreed For European, Canadian And Mexican Markets
Biocon has added to its roster of liraglutide partners by striking a fresh deal in Korea with Handok for the chronic weight management treatment.
